Finance

Beta
Lists
536565:BOM
Novelix Pharmaceuticals Ltd
₹75.82
-5.00%
(-3.99) 1D
Jun 19, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 536565...
Open
₹78.00
High
₹79.00
Low
₹75.82
Mkt. cap
1.81B
Avg. vol.
15.92K
Volume
14.22K
P/E ratio
62.66
52-wk high
₹92.00
52-wk low
₹29.33
EPS
₹1.21
No. of employees
8
Open
₹78.00
High
₹79.00
Low
₹75.82
Mkt. cap
1.81B
Avg. vol.
15.92K
Volume
14.22K
P/E ratio
62.66
52-wk high
₹92.00
52-wk low
₹29.33
EPS
₹1.21
No. of employees
8
News stories
From sources across the web
About Novelix Pharmaceuticals Ltd
CEO-
Employees8
Founded1994
Headquarters-
SectorHealth care provider
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
223.51M
363.91M
484.03M
251.94M
Cost of goods sold
217.79M
351.88M
468.49M
228.99M
Cost of revenue
217.79M
351.88M
468.49M
228.99M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.65M
1.42M
1.73M
2.39M
Operating expense
4.03M
4.84M
2.71M
10.62M
Total operating expenses
221.82M
356.73M
471.20M
239.61M
Operating income
1.69M
7.19M
12.83M
12.33M
Other non operating income
-
-
-
-
EBT including unusual items
1.69M
7.19M
12.83M
12.33M
EBT excluding unusual items
1.69M
7.19M
12.83M
12.33M
Income tax expense
624.00K
1.86M
2.79M
3.21M
Effective tax rate
36.84%
25.83%
21.72%
26.04%
Other operating expenses
2.28M
3.29M
673.00K
7.76M
Net income
1.07M
5.33M
10.04M
9.12M
Net profit margin
0.48%
1.46%
2.08%
3.62%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
110.00K
138.00K
303.00K
461.00K
EBITDA
1.79M
7.31M
12.93M
12.58M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more